Trial record 1 of 1 for:    Metformin in Combination with Vincristine, Irinotecan, and Temozolomide
Previous Study | Return to List | Next Study

Metformin in Children With Relapsed or Refractory Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by H. Lee Moffitt Cancer Center and Research Institute
Sponsor:
Collaborator:
Pediatric Cancer Foundation
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT01528046
First received: February 3, 2012
Last updated: July 6, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)